M Misiek
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Microbial Natural Products and Biosynthesis
Papers in
-
- Antibiotic Resistance in Bacteria 14
- Pharmacology 19
- Antibiotics Pharmacokinetics and Efficacy 13
- Microbial Natural Products and Biosynthesis 6
- Co-authors
- F. LeitnerK. E. PriceT. A. PursianoR. E. BuckR E KesslerA. GourévitchJ V DesiderioJ. Lein
- Journals
- Antimicrobial Agents and Chemotherapy (8 papers)The Journal of Antibiotics (4 papers)Journal of Medicinal Chemistry (2 papers)Journal of Bacteriology (1 paper)Canadian Journal of Chemistry (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
M Misiek
25 papers receiving 399 citations
Peers
Comparison fields: 5 of 72
- Molecular Medicine 226
- Pharmacology 346
- Applied Microbiology and Biotechnology 31
- Clinical Biochemistry 37
- Infectious Diseases 85
Countries citing papers authored by M Misiek
This map shows the geographic impact of M Misiek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Misiek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Misiek more than expected).
Fields of papers citing papers by M Misiek
This network shows the impact of papers produced by M Misiek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Misiek. The network helps show where M Misiek may publish in the future.
Co-authors
The 23 scholars most cited alongside M Misiek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Telomycin, a new antibiotic. | 2000 | 6 |
| 2 | 1987 | 55 | |
| 3 | 1985 | 141 | |
| 4 | 1980 | 17 | |
| 5 | 1980 | 6 | |
| 6 | 1977 | 2 | |
| 7 | 1976 | 43 | |
| 8 | 1973 | 24 | |
| 9 | 1973 | 7 | |
| 10 | 1973 | 9 | |
| 11 | 1972 | 66 | |
| 12 | 1972 | 2 | |
| 13 | 1970 | 5 | |
| 14 | Laboratory studies with a new cephalosporanic acid derivative. | 1969 | 14 |
| 15 | 1969 | 4 | |
| 16 | 1969 | 11 | |
| 17 | Microbiological and pharmacological evaluation of BL-C 43, a new semisynthetic derivative of coumermycin A1. | 1969 | 1 |
| 18 | Mycorhodin, a new antibiotic. | 1959 | 3 |
| 19 | Miamycin, a new antibiotic. | 1957 | 7 |
| 20 | Competitive inhibition by bromide of incorporation of chloride into the tetracycline molecule. | 1955 | 10 |
About M Misiek
M Misiek is a scholar working on Molecular Medicine, Pharmacology, Infectious Diseases, Toxicology and Organic Chemistry, having authored 26 papers that have together received 497 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (14 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Microbial Natural Products and Biosynthesis (6 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers), Synthesis of β-Lactam Compounds (4 papers), Cancer therapeutics and mechanisms (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). The work is most often cited by research in Molecular Medicine (226 citations), Pharmacology (346 citations), Applied Microbiology and Biotechnology (31 citations), Clinical Biochemistry (37 citations) and Infectious Diseases (85 citations). M Misiek has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include F. Leitner, K. E. Price, T. A. Pursiano, R. E. Buck, R E Kessler, A. Gourévitch, J V Desiderio, J. Lein, I. R. Hooper and Bernard Heinemann. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Journal of Antibiotics, Journal of Medicinal Chemistry, Journal of Bacteriology and Canadian Journal of Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.